Annual Interest Coverage Ratio
N/A
December 31, 2023
Summary
- IKT annual interest coverage ratio is not available.
Performance
IKT Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Coverage Ratio
N/A
September 30, 2024
Summary
- IKT quarterly interest coverage ratio is not available.
Performance
IKT Quarterly Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Coverage Ratio Formula
Interest Coverage Ratio = EBIT
Interest Expense
EBIT
Interest Expense
Interest Expense
IKT Interest Coverage Ratio Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
IKT Interest Coverage Ratio Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
Inhibikase Therapeutics Interest Coverage Ratio History
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | -742.02(+674.0%) | -25.21 K(+12.8%) |
Sep 2021 | - | -22.36 K(+6534.1%) |
Jun 2021 | - | -336.97(+51.5%) |
Mar 2021 | - | -222.48(+31.5%) |
Dec 2020 | -95.87 | -169.13(+75.8%) |
Sep 2020 | - | -96.19(+83.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2020 | - | -52.39(-28.2%) |
Mar 2020 | - | -72.97(+33.1%) |
Dec 2019 | -229.76(+228.0%) | -54.84(-64.5%) |
Sep 2019 | - | -154.44(-63.0%) |
Jun 2019 | - | -417.61(-10.8%) |
Mar 2019 | - | -468.30 |
Dec 2018 | -70.04 | - |
FAQ
- What is the all time high annual interest coverage ratio for Inhibikase Therapeutics?
- What is the all time high quarterly interest coverage ratio for Inhibikase Therapeutics?
What is the all time high annual interest coverage ratio for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual interest coverage ratio is -70.04
What is the all time high quarterly interest coverage ratio for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly interest coverage ratio is -52.39